PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan

BioNexus Gene Lab Corp Common stock (BGLC) Sharpe Ratio: -0.54

Equity · Currency in USD · Last updated Jul 17, 2026

BGLC's Sharpe Ratio of -0.54 indicates that for each unit of volatility, it generates -0.54 units of excess return above the risk-free rate. The ratio is calculated using historical daily returns over the past 12 months (as of Jul 17, 2026).

Sharpe uses total volatility (standard deviation) which includes both upside and downside price movements, making it useful for comparing risk-adjusted returns across different assets. For how to read this number and when it can mislead, see Sharpe Ratio Explained.

BGLC Sharpe Ratio Rank

BGLC Sharpe Ratio Rank: 20.020
Concerning

BGLC ranks above 20.0% of all investments in our database based on Sharpe Ratio over the past 12 months, indicating weak returns relative to total risk taken. Securities are ranked from 0 (worst) to 100 (best).

What moves the rank

  • Strong returns with low total volatility → Higher rank
  • High volatility (both upside and downside) → Lower rank
  • Consistent returns → Higher rank than volatile returns of same magnitude
  • Sharp drawdowns increase volatility → Lower rank

What you can do with this information

  • Weak risk-adjusted returns relative to category peers
  • Evaluate whether this holding aligns with your risk-return objectives
  • Consider reducing exposure or re-evaluating position size
  • Review higher-ranked alternatives in the same category

BGLC Sharpe Ratio Market Positioning

The chart shows BGLC's Sharpe Ratio relative to all stocks on our platform, with color zones indicating percentile rankings. Higher ratios indicate better risk-adjusted returns.

  • Red zone (bottom 25%): -0.43 or lower
  • Yellow zone (middle 50%): -0.43 to 1.01
  • Green zone (top 25%): 1.01 or higher
  • Top 1%: 4.47+
  • Median: 0.13 — half of all investments score higher

How it compares to other similar stocks

The table compares BioNexus Gene Lab Corp Common stock's Sharpe Ratio with other stocks in the Specialty Chemicals industry across multiple time periods, showing how BGLC's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jul 17, 2026.

SymbolName1Y Sharpe Ratio5Y Sharpe Ratio10Y Sharpe RatioAll Time Sharpe Ratio
ALTOAlto Ingredients, Inc.3.54
REXREX American Resources Corporation2.34
PRMPerimeter Solutions, SA2.17
NOPMFNeo Performance Materials Inc.2.06
LWLGLightwave Logic, Inc.1.92
ODCOil-Dri Corporation of America1.87
GPREGreen Plains Inc.1.86
NGVTIngevity Corporation1.55
ECVTEcovyst Inc.1.54
KOPKoppers Holdings Inc.1.42
BGLCBioNexus Gene Lab Corp Common stock-0.54

S&P 500 Index

How to choose period

Historical Sharpe Ratio

The chart shows BGLC's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when BGLC consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading charts...

Sharpe Ratio Calculator

How does BGLC fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio